Intellia Therapeutics Inc
(LTS:0JBU)
$
11.86
0 (0%)
Market Cap: 1.22 Bil
Enterprise Value: 662.64 Mil
PE Ratio: 0
PB Ratio: 1.27
GF Score: 51/100 Intellia Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Mar 10, 2020 / 07:20PM GMT
Release Date Price:
$13.21
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
Thank you, everyone. My name is Gena Wang. I'm SMID-cap biotech analyst at Barclays. I first hope that everyone stay healthy, and I would like to thank all the participants, investors and companies, and especially our event team and corporate access team who made this virtual health care conference possible.
With that, I would like to introduce our next presenter, John Leonard, President and the Chief Executive Officer from Intellia. Hi, John.
John M. Leonard
Intellia Therapeutics, Inc. - President, CEO & Director
Hi, Gena. How are you?
Huidong Wang;John M. Leonard
Barclays Bank PLC, Research Division - Research Analyst;Intellia
Good, good. Maybe I will start with more of the big picture question. I know you don't have a slide for investors. Maybe wondering if you could just give us a quick overview of Intellia, so that would be helpful for those investors who are not familiar with the company.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot